The Bone Marrow Comprehensive Report : Advances in Molecular and Cytogenetic Risk Stratification in AML and MDS
暂无分享,去创建一个
[1] J. Vardiman,et al. Acute Myeloid Leukemia With Myelodysplasia-Related Changes. , 2015, American journal of clinical pathology.
[2] Tina Hambuch,et al. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. , 2012, The Journal of molecular diagnostics : JMD.
[3] D. Arber,et al. DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups , 2012, British journal of haematology.
[4] D. Neuberg,et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[6] Isaac S. Kohane,et al. Technical desiderata for the integration of genomic data into Electronic Health Records , 2012, J. Biomed. Informatics.
[7] N. Socci,et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. , 2012, The New England journal of medicine.
[8] S. Salzberg,et al. Repetitive DNA and next-generation sequencing: computational challenges and solutions , 2011, Nature Reviews Genetics.
[9] D. Neuberg,et al. Clinical effect of point mutations in myelodysplastic syndromes. , 2011, The New England journal of medicine.
[10] Fabien Campagne,et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. , 2010, Cancer cell.
[11] W. Grody,et al. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. , 2008, The Journal of molecular diagnostics : JMD.
[12] Amy E. Hawkins,et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.
[13] M. Gulley,et al. Clinical laboratory reports in molecular pathology. , 2007, Archives of pathology & laboratory medicine.
[14] B. Nathwani,et al. Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. The Ad Hoc Committee on reporting of lymphoid neoplasms. , 2002, Human pathology.
[15] L. Peterson,et al. Protocol for the examination of specimens from patients with hematopoietic neoplasms of the bone marrow: a basis for checklists. , 2002, Archives of pathology & laboratory medicine.
[16] K Wheatley,et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.
[17] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[18] C. Bloomfield,et al. The 2008 Revision of the WHO Classification of Myeloid Neoplasms and Acute Leukemia : Rationale and Important Changes , 2009 .
[19] S. Trent Rosenbloom,et al. Quill: A Novel Approach to Structured Reporting , 2003, AMIA.
[20] M. Slovak,et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. , 2000, Blood.